Showing results (1781-1790 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|August 10, 2016
Brivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with EpilepsySheridan M HoyCNS Drugs|August 30, 2025
Association Between Opioid Analgesics and Suicide Attempts: A Nationwide French Case-Crossover StudyBénédicte Nobile, Erika Nogue, M C Picot, et al.CNS Drugs|August 14, 2016
CNS Adverse Effects of Nonsteroidal Anti-Inflammatory Drugs : Therapeutic ImplicationsA Morgan, D ClarkCNS Drugs|August 14, 2016
Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their ManagementA Dalvi, B FordCNS Drugs|October 26, 2019
Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple SclerosisCarolina Gabri Nicoletti, Doriana Landi, Fabrizia Monteleone, et al.CNS Drugs|April 18, 2020
Dose Adjustment of Stimulants for Children with Attention-Deficit/Hyperactivity Disorder: A Retrospective Chart Review of the Impact of Exceeding Recommended DosesLindsey Ross, Veena Sapre, Christina Stanislaus, et al.CNS Drugs|July 13, 2015
Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's DiseaseDaphne Robakis, Stanley FahnCNS Drugs|July 30, 2016
Treatment for Rheumatoid Arthritis and Risk of Alzheimer's Disease: A Nested Case-Control AnalysisRichard C Chou, Michael Kane, Sanjay Ghimire, et al.CNS Drugs|July 19, 2015
Alzheimer's Disease: Lessons Learned from Amyloidocentric Clinical TrialsAndreas Soejitno, Anastasia Tjan, Thomas Eko PurwataCNS Drugs|July 29, 2016
(S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective StudyJulia Höfler, Alexandra Rohracher, Gudrun Kalss, et al.Pageof 211